HomeInvestor information
Help shape the future of PTSD treatment.
Evren is seeking support for the final stages of FDA clinical trials and go-to-market activities for the Phoenix CR system.
EVRENBioelectronic medicine
01
An urgent unmet need
Millions of Americans experience PTSD each year, and many continue seeking relief beyond current drugs and therapy.
02
A differentiated platform
Evren combines a discreet, non-invasive taVNS device with research-grade programmability, adherence monitoring and data capture.
03
Important notice
Securities are not offered through this website and no money or other consideration is being solicited. Any investment is subject to Federal and State securities laws and authorized offering documents.
Next step
Contact the Evren team